Electric Suction Apparatus Suction Machine

Name: Electric Suction Apparatus Suction Machine
Brand: Perlong Medical Equipment Co., Ltd.
SKU: 686212622

Jiangsu, ChinaPerlong Medical Equipment Co., Ltd.

US$1.00-500.00

1 Piece

Product profile

Customization

Available

Type

Surgical

Theory

Electrotherapeutics

Model NO.

DX23D

LCD Display

Without LCD Display

Group

All People

Color

White

Max Vacuum

≥0.09mpa(680mmhg)

Free Airflow

≥20L/Min(in Pump Exit:≥30L/Min)

Liquid Storage Bottle

2500ml×2

Power Supply

AC220V±10%, 50Hz

Transport Package

Carton

Specification

ISO

Trademark

Perlong

Origin

China Jiangsu Nanjing

HS Code

9018909010

Production Capacity

50 Units/Month

Key features

High Vacuum Performance: Efficient single rotor pump produces vacuum higher than 0.09MPa (680mmHg).

Large Collection Capacity: Equipped with two 2500ml glass bottles calibrated in 100ml steps.

Dual Control Options: Features both hand-switch and foot-switch for flexible operation.

Compact and Portable: Designed with casters and a foldable handle for easy movement.

Precision Vacuum Regulation: Adjuster knob allows setting vacuum levels from 0.02 to 0.09 Mpa.

Safety Protection: Includes overflow protection and air filter for safe operation.

Durable Construction: Oil impregnated vanes ensure long trouble-free service.

Fast Delivery: Delivery time is 7-10 days after payment.

Company profile

Perlong Medical Equipment Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2003-09-09Nearest Port: Shanghai, NingboAverage Response Time: ≤15hTerms of Payment: LC, T/T, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryPerlong Medical Equipment Co., Ltd. is a China-based limited company in Nanjing, Jiangsu, engaged in medical-equipment trade and manufacturing. The supplier states that it has operated since 2003, possesses self-operated import and export rights, and derives 90% of sales from exports. Its product scope includes patient monitors, anesthesia, X-ray, laboratory, ECG, ultrasound, dental, ventilator, and biochemistry equipment. ISO 13485 and ISO 9001 management certifications are reported, along with 11–20 R&D engineers, 11–20 quality-control staff, and three production lines. The company claims exports to more than 140 countries and cooperation with WHO, UNDP, and UNICEF, but these claims are not independently substantiated in the provided data. The available trade records show transactions involving buyers in Uzbekistan and Tanzania, including patient-monitor shipments. Evidence is insufficient to assess financial credibility, customization capability, or the full extent of after-sales support.

Supplier typeThe supplier is identified as both a trading company and manufacturer/factory, operating as a limited company in Nanjing, China, with medical equipment as its commercial focus. Its stated product range and company profile support classification as a medical-equipment supplier with combined trading and manufacturing activities.

CertificationsThe supplier reports ISO 13485 and ISO 9001 management-system certifications. It also states that most products have obtained ISO certifications and that some have met CE and FDA requirements, although the specific certified products and certificate details are not provided.

Production capacityThe company is described as a manufacturer/factory as well as a trading company, with three production lines, 11–20 quality-control staff, and a factory location in Nanjing. Its stated manufacturing role and operating resources support production capability, although product-specific capacity and utilization are not provided.

Client casesThe supplier claims cooperation with WHO, UNDP, and UNICEF and exports to more than 140 countries. The trade records additionally identify ООО BAYMED INNOVATION in Uzbekistan and KAIRUKI HOSPITAL in Tanzania, including patient-monitor transactions; these records demonstrate named transaction cases but do not independently validate the broader international-client claims.